<DOC>
	<DOCNO>NCT02162966</DOCNO>
	<brief_summary>Colistin rapidly act bactericidal antimicrobial agent possess post antibiotic effect MDRO Gram-negative bacteria , Pseudomonas aeruginosa , Acinetobacterbaumannii , Klebsiella pneumonia .</brief_summary>
	<brief_title>Safety Efficacy Study High Dose Colistin</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>1 . Patient age equal 18 year old . 2 . Patient clinical sign symptom infection suspect proven infection due Carbapenem resistant microorganism . 3 . Patient start Empirical therapy Colistin positive MDRO within 5 day empirical therapy . 1 . Patient age le 18 year . 2 . Pregnant patient . 3 . If receive Colistin treatment le 72 hour . 4 . Renal Replacement Therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>colistin</keyword>
	<keyword>ICU</keyword>
	<keyword>critical care</keyword>
</DOC>